Literature DB >> 17040255

HER-2 overexpression and targeted treatment by trastuzumab in a very old patient with gastric cancer.

T Inui1, A Asakawa, Y Morita, S Mizuno, T Natori, A Kawaguchi, M Murakami, Y Hishikawa, A Inui.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17040255     DOI： 10.1111/j.1365-2796.2006.01715.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN： 0954-6820            Impact factor:   8.989


× No keyword cloud information.
  9 in total

Review 1.  Locally advanced and metastatic gastric cancer: current management and new treatment developments.

Authors:  Kathryn Field; Michael Michael; Trevor Leong
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 2.  ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Authors:  William H Fiske; David Threadgill; Robert J Coffey
Journal:  Exp Cell Res       Date:  2008-11-07       Impact factor: 3.905

3.  Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma.

Authors:  Carlos Gómez-Martín; Angel Concha; José María Corominas; Tomás García-Caballero; Elena García-García; Mar Iglesias; José Antonio López; Santiago Ramón y Cajal; Federico Rojo; José Palacios; Francisco Vera-Sempere; Enrique Aranda; Ramon Colomer; Pilar García-Alfonso; Pilar Garrido; Fernando Rivera; Fernando López-Ríos
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

4.  Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.

Authors:  Hai-Zhen Dang; Yang Yu; Shun-Chang Jiao
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

5.  Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology.

Authors:  Dimitrios Tsapralis; Ioannis Panayiotides; George Peros; Theodore Liakakos; Eva Karamitopoulou
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

6.  Simultaneous detection of expression and gene mutations of HER2/neu in Chinese patients with gastric cancer.

Authors:  Xiuli Zhang; Jianhui Qu; Gang Sun; Jing Yang; Yunsheng Yang
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

7.  Comparative study on overexpression of HER2/neu and HER3 in gastric cancer.

Authors:  Xiu Li Zhang; Yun Sheng Yang; Dong Ping Xu; Jian Hui Qu; Ming Zhou Guo; Yan Gong; Jin Huang
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

8.  Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancers.

Authors:  Florian Lordick; Dirk Jäger
Journal:  Gastrointest Cancer Res       Date:  2008-07

Review 9.  The advent of precision therapy in gastrointestinal malignancies: Targeting the human epidermal growth factor receptor family in colorectal and esophagogastric cancer.

Authors:  Danielle Desautels; Craig Harlos; Piotr Czaykowski
Journal:  J Carcinog       Date:  2014-11-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.